<DOC>
	<DOCNO>NCT00878072</DOCNO>
	<brief_summary>This study ass safety , tolerability single 1500 mg dose famciclovir 50 adolescent recurrent herpes labialis . Eight 50 adolescent also participate pharmacokinetics ( PK ) assessment famciclovir single 1500 mg dose</brief_summary>
	<brief_title>Safety Pharmacokinetics Famciclovir Single 1500 mg Dose Adolescents With Recurrent Herpes Labialis</brief_title>
	<detailed_description>Uncontrolled study</detailed_description>
	<mesh_term>Herpes Labialis</mesh_term>
	<mesh_term>Famciclovir</mesh_term>
	<mesh_term>2-Aminopurine</mesh_term>
	<criteria>Outpatient male females 12 &lt; 18 year age General good health document history typical recurrent herpes labialis Prodromal symptom active lesion suggestive recurrent episode herpes labialis ( i.e . cold sore past ) , onset exceed 24 hour time study drug administration Adolescents participate PK part study may enrol without active herpes labialis recurrence onset signs/symptoms recurrent herpes labialis episode longer 24 hour study drug administration , All adolescent participate pharmacokinetics assessment must fast least 8 hour prior Visit 1 willing fast additional 2 hour study drug administration Use investigational drug within 30 day enrollment History hypersensitivity famciclovir penciclovir Inability swallow tablet Body weight less 40 kg History malabsorption , unless condition like celiac disease stable well control , previous gastrointestinal surgery radiation therapy could affect drug absorption metabolism , condition could interfere drug absorption , distribution , metabolism , excretion Known renal insufficiency ( calculated creatinine clearance &lt; 60 mL/min ) Known severe hepatic impairment ( ChildPugh Class C ) Significant skin disease atopic dermatitis eczema would interfere assessment oral/labial lesion Known immunocompromised receive systemic use topical immunosuppressive agent ( include corticosteroid , tacrolimus picrolimus ) within 30 day enrollment Concomitant use probenecid Pregnant nursing ( lactate ) female Females childbearing potential , UNLESS use two birth control method . The two method double barrier method barrier method plus hormonal method .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Herpes labialis</keyword>
	<keyword>cold sore</keyword>
	<keyword>herpes simplex type 1</keyword>
</DOC>